News

First MRI-compatible implantable defibrillator approved

Publish date: September 18, 2015

 

References

The Evera MRI Study was sponsored by Medtronic, which produces and will market the Evera ICD. Dr. Gold has been a consultant to and has received research and speaker funding from Medtronic as well as from Boston Scientific and St. Jude. Dr. Passman has received research support from Medtronic but not for work on ICDs.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

ESC: New review yields reassuring digoxin data
MDedge Internal Medicine
Heart failure’s surprises keep coming
MDedge Internal Medicine
VIDEO: Adverse ventilation effect means rethinking Cheyne-Stokes respiration
MDedge Internal Medicine
ESC: CERTITUDE casts doubt on defibrillator benefit in CRT
MDedge Internal Medicine
Collaboration helped reduce heart failure readmissions
MDedge Internal Medicine
ESC: Most heart failure patients’ rehospitalizations are for other reasons
MDedge Internal Medicine
VIDEO: Patients use CardioMEMS feedback to improve self-management
MDedge Internal Medicine
ESC: Heart failure risk climbs early in childhood cancer survivors
MDedge Internal Medicine
ESC: Further data indicate no excess heart failure risk with lixisenatide or sitagliptin
MDedge Internal Medicine
ESC: Noncardiac surgery in HCM patients warrants special attention
MDedge Internal Medicine

Related Articles